European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...
Medscape3d
Alzheimer's Disease
Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
AFP on MSN11h
European Watchdog Partially Approves New Alzheimer's Drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...
News Medical1h
Researchers use cerebrospinal fluid to unlock pathways in Alzheimer's disease
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box ...
NBC News on MSN11d
Alzheimer's researchers say brain stimulation device may slow symptoms
In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...
Ticker: Biogen Alzheimer’s drug gets second look in EU; Ford takes $165M hit on slow recall
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
InMed Pharmaceuticals Makes Progress on Alzheimer’s Drug
InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals has made significant strides in its pharmaceutical programs, ...
Biogen up 5% after EMA recommends Leqembi for early Alzheimer’s disease
EST Biogen (BIIB) up 5% after EMA recommends Leqembi for early Alzheimer’s disease Published first on TheFly – the ultimate ...
Laredo Morning Times2d
Popeyes of Laredo contributes profits to the Walk To End Alzheimer’s of Laredo
"Popeyes of Laredo is always looking to give back to the community and sees the need for Alzheimer’s awareness and support," ...
News Medical on MSN2d
Scientists uncover cerebrospinal fluid markers for Alzheimer's detection and treatment
Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...
Gradual dosing of Lilly Alzheimer's drug cuts brain-swelling risk, study finds
Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...